The pro- and anti-inflammatory properties of human antigen-presenting cells expressing the high affinity receptor for IgE (FcεRI)

Immunobiology

Volumn 212, Issue 6, 2007, Pages 499-503

  Bieber, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antigen presenting cells; IgE receptor

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN E RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; ATOPY; CELL ACTIVITY; CELL SECRETION; CELL STRUCTURE; CELL SURFACE; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME SYNTHESIS; EPIDERMIS CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LANGERHANS CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SKIN CELL; TH1 CELL; TH2 CELL;

EID: 34249692571     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.03.001     Document Type: Article

References (41)

1. Allam J.P., Novak N., Fuchs C., Asen S., Berge S., Appel T., Geiger E., Kochan J.P., and Bieber T. Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. J. Allergy Clin. Immunol. 112 (2003) 141-148
2. Allam J.P., Niederhagen B., Bucheler M., Appel T., Betten H., Bieber T., Berge S., and Novak N. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 61 (2006) 166-172
3. Bieber T. IgE-binding molecules on human Langerhans cells. Acta Derm. Venereol. Suppl. (Stockholm) 176 (1992) 54-57
4. Bieber T. Fc epsilon RI on human epidermal Langerhans cells: an old receptor with new structure and functions. Int. Arch. Allergy Immunol. 113 (1997) 30-34
5. Bieber T., Dannenberg B., Prinz J.C., Rieber E.P., Stolz W., Braun-Falco O., and Ring J. Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J. Invest. Dermatol. 93 (1989) 215-219
6. Bieber T., Rieger A., Neuchrist C., Prinz J.C., Rieber E.P., Boltz-Nitulescu G., Scheiner O., Kraft D., Ring J., and Stingl G. Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon. J. Exp. Med. 170 (1989) 309-314
7. Bieber T., and Braun-Falco O. IgE-bearing Langerhans cells are not specific to atopic eczema but are found in inflammatory skin diseases. J. Am. Acad. Dermatol. 24 (1991) 658-659
8. Bieber T., de la Salle H., Wollenberg A., Hakimi J., Chizzonite R., Ring J., Hanau D., and de la Salle C. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J. Exp. Med. 175 (1992) 1285-1290
9. Bieber T., Kraft S., Jurgens M., Strobel I., Haberstok J., Tomov H., Regele D., de la Salle H., Wollenberg A., and Hanau D. New insights in the structure and biology of the high affinity receptor for IgE (Fc epsilon RI) on human epidermal Langerhans cells. J. Dermatol. Sci. 13 (1996) 71-75
10. Bratton D.L., Hamid Q., Boguniewicz M., Doherty D.E., Kailey J.M., and L`eung D.Y. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J. Clin. Invest. 95 (1995) 211-218
11. Bruynzeel-Koomen C., van Wichen D.F., Toonstra J., Berrens L., and Bruynzeel P.L. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch. Dermatol. Res. 278 (1986) 199-205
12. Hoetzenecker W., Ecker R., Kopp T., Stuetz A., Stingl G., and Elbe-Burger A. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 115 (2005) 1276-1283
13. Jurgens M., Wollenberg A., Hanau D., de la Salle H., and Bieber T. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. J. Immunol. 155 (1995) 5184-5189
14. Katoh N., Kraft S., Wessendorf J.H., and Bieber T. The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J. Clin. Invest. 105 (2000) 183-190
15. Kerschenlohr K., Decard S., Przybilla B., and Wollenberg A. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J. Allergy Clin. Immunol. 111 (2003) 869-874
16. Klubal R., Osterhoff B., Wang B., Kinet J.P., Maurer D., and Stingl G. The high-affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients. Invest. Dermatol. 108 (1997) 336-342
17. Kraft S., Wessendorf J.H., Hanau D., and Bieber T. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J. Immunol. 161 (1998) 1000-1006
18. Kraft S., Wessendorf J.H., Haberstok J., Novak N., Wollenberg A., and Bieber T. Enhanced expression and activity of protein-tyrosine kinases establishes a functional signaling pathway only in FcepsilonRIhigh Langerhans cells from atopic individuals. J. Invest. Dermatol. 119 (2002) 804-811
19. Kraft S., Novak N., Katoh N., Bieber T., and Rupec R.A. Aggregation of the high-affinity IgE receptor Fc(epsilon)RI on human monocytes and dendritic cells induces NF-kappaB activation. J. Invest. Dermatol. 118 (2002) 830-837
20. Leung D.Y., Schneeberger E.E., Siraganian R.P., Geha R.S., and Bhan A.K. The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitis. Clin. Immunol. Immunopathol. 42 (1987) 328-337
21. Mudde G.C., Van Reijsen F.C., Boland G.J., de Gast G.C., Bruijnzeel P.L., and Bruijnzeel-Koomen C.A. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology 69 (1990) 335-341
22. Novak N., and Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J. Am. Acad. Dermatol. 53 (2005) S171-S176
23. Novak N., Bieber T., and Katoh N. Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J. Immunol. 167 (2001) 797-804
24. Novak N., Kraft S., Haberstok J., Geiger E., Allam P., and Bieber T. A reducing microenvironment leads to the generation of FcepsilonRIhigh inflammatory dendritic epidermal cells (IDEC). J. Invest. Dermatol. 119 (2002) 842-849
25. Novak N., Tepel C., Koch S., Brix K., Bieber T., and Kraft S. Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors. J. Clin. Invest. 111 (2003) 1047-1056
26. Novak N., Allam J.P., Hagemann T., Jenneck C., Laffer S., Valenta R., Kochan J., and Bieber T. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J. Allergy Clin. Immunol. 114 (2004) 364-370
27. Novak N., Kwiek B., and Bieber T. The mode of topical immunomodulators in the immunological network of atopic dermatitis. Clin. Exp. Dermatol. 30 (2005) 160-164
28. Schuller E., Oppel T., Bornhovd E., Wetzel S., and Wollenberg A. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis. J. Allergy Clin. Immunol. 114 (2004) 137-143
29. Segre J.A. Epidermal barrier formation and recovery in skin disorders. J. Clin. Invest. 116 (2006) 1150-1158
30. Sigalov A.B. Multichain immune recognition receptor signaling: different players, same game?. Trends Immunol. 25 (2004) 583-589
31. von Bubnoff D., Matz H., Frahnert C., Rao M.L., Hanau D., de la Salle H., and Bieber T. FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses. J. Immunol. 169 (2002) 1810-1816
32. von Bubnoff D., Bezold G., Matz H., Hanau D., De La Salle H., and Bieber T. Quantification of indoleamine 2,3-dioxygenase gene induction in atopic and non-atopic monocytes after ligation of the high-affinity receptor for IgE, Fc(epsilon)RI and interferon-gamma stimulation. Clin. Exp. Immunol. 132 (2003) 247-253
33. von Bubnoff D., Hanau D., Wenzel J., Takikawa O., Hall B., Koch S., and Bieber T. Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle?. J. Allergy Clin. Immunol. 112 (2003) 854-860
34. von Bubnoff D., Bausinger H., Matz H., Koch S., Hacker G., Takikawa O., Bieber T., Hanau D., and de la Salle H. Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. J. Invest. Dermatol. 123 (2004) 298-304
35. von Bubnoff D., Fimmers R., Bogdanow M., Matz H., Koch S., and Bieber T. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin. Exp. Allergy 34 (2004) 1056-1063
36. Wang B., Rieger A., Kilgus O., Ochiai K., Maurer D., Fodinger D., Kinet J.P., and Stingl G. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J. Exp. Med. 175 (1992) 1353-1365
37. Werner Y., and Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm. Venereol. 65 (1985) 102-105
38. Wilson D.R., Lima M.T., and Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60 (2005) 4-12
39. Wollenberg A., Kraft S., Hanau D., and Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J. Invest. Dermatol. 106 (1996) 446-453
40. Wollenberg A., Wen S., and Bieber T. Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod. Cytometry 37 (1999) 147-155
41. Wollenberg A., Sharma S., von Bubnoff D., Geiger E., Haberstok J., and Bieber T. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J. Allergy Clin. Immunol. 107 (2001) 519-525